Avalo Therapuetics (AVTX) Misses Q1 EPS by 125c

Avalo Therapuetics (NASDAQ: AVTX) reported Q1 EPS of ($1.25).

For earnings history and earnings-related data on Avalo Therapuetics (AVTX) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Lobe Sciences closes $2.16M private placement for S-100 drug program
• Air Conditioning Company in South Florida, Peachy Keen Air Conditioning, Plumbing, Heating, Launches Safety Initiative